Aster DM Healthcare Limited has informed the Exchange regarding Outcome of Board Meeting held on March 10, 2026.
ASTERDM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Aster DM Healthcare, at its meeting on March 10, 2026, approved the appointment of Dr. Azad Moopen (DIN: 00159403) as Executive Director, a role he is being redesignated to from his current position of Managing Director. His term runs from April 15, 2026 to May 28, 2028 and is subject to shareholder approval via postal ballot. Dr. Moopen, the founder of the company, will also continue to serve as Chairman. The disclosure also notes that his daughters — Ms. Alisha Moopen (Deputy Managing Director) and Dr. Zeba Azad Moopen (Non-Executive Director) — are already on the Board.
This is a continuity move rather than a leadership change — the founder stays engaged in an executive capacity while formally stepping back from the Managing Director title, pointing to a structured succession plan. Shareholders should watch for the postal ballot outcome and any further clarity on day-to-day management responsibilities.